Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.182\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) C/C(CC(=O)Nc1cccc(C(F)(F)F)c1)=N\NC(=O)c1ccncc1
(b) COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc2ccccc2n1
Answer: b. COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc2ccccc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc2ccccc2n1
COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc2ccccc2n1
methyl (2S)-3-phenyl-2-(quinoline-2-carbonylamino)propanoate